The rare species of Ebola involved - known as Bundibugyo - kills around a third of those infected and has no proven vaccine ...

Since 2023, Moderna and Korea University have been developing a new mRNA vaccine for hantavirus. The work has been promising so far, but a finished product isn't likely coming any time soon.

With no approved vaccine for the fast-growing Ebola outbreak in the DRC, experts weigh testing one with unknown protection.

Scientists from China have developed a new broad-spectrum mRNA vaccine that could provide long-term protection against the ...

By Mariam Sunny and Jennifer Rigby May 21 (Reuters) - Global health authorities are racing to identify medical options to ...

A hantavirus vaccine is currently in preclinical development, but a publicly available shot is likely years away. Other similar research efforts are also in the very early stages.

Vanderbilt University Medical Center's vaccine center has the antibodies to make a hantavirus vaccine. But to get it into ...

A decade after Ebola vaccines changed outbreak response, a new epidemic in central Africa is caused by a strain the world ...

Researchers at Oxford University are developing the novel jab targeting the rare strain. The World Health Organization says ...

The Covid vaccination programme was unprecedented. Never before had vaccines been developed so quickly or rolled out so rapidly. What would normally takes years in research and clinical trials, was ...

Global health authorities are racing to identify medical options to help contain an Ebola outbreak in eastern Democratic ...